- By insider
CEO of Odonate Therapeutics Inc (ODT) Kevin C Tang bought 39,765 shares of ODT on 10/25/2018 at an average price of $15.35 a share. The total cost of this purchase was $610,393.
Odonate Therapeutics Inc is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer. It is developing tesetaxel an chemotherapy agent used in the treatment of cancer. Odonate Therapeutics Inc has a market cap of $424.700 million; its shares were traded at around $15.83 .
-
Warning! GuruFocus has detected 4 Warning Sign with KMG. Click here to check it out.
-
The intrinsic value of ODT
CEO Recent Trades:
-
CEO, 10% Owner Kevin C Tang bought 39,765 shares of ODT stock on 10/25/2018 at the average price of $15.35. The price of the stock has increased by 3.13% since.
-
CEO, 10% Owner Kevin C Tang bought 40,000 shares of ODT stock on 09/28/2018 at the average price of $19.16. The price of the stock has decreased by 17.38% since.
-
CEO, 10% Owner Kevin C Tang bought 40,000 shares of ODT stock on 09/26/2018 at the average price of $19.75. The price of the stock has decreased by 19.85% since.
For the complete insider trading history of ODT, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 4 Warning Sign with KMG. Click here to check it out.
-
The intrinsic value of ODT